Management of Co-Existing Glaucoma and Cataract
completed: May 2001 Investigators Henry D. Jampel, MD, MHS
David S. Friedman, MD, MPH
Oliver D. Schein, MD, MHS
Lisa H. Lubomski, PhD
Karen A. Robinson, MSc
Eric B. Bass, MD, MPH
Questions
The questions addressed were as follows: What are the risks and benefits of staged versus combined procedures? What is the effect of cataract surgery on short and long-term intraocular pressure control in open angle glaucoma patients? What is the effect of glaucoma surgery upon the development and progression of cataract? What are the risks and benefits of anti-fibrosis agents? What are the risks and benefits of trabeculectomy versus endoscopic laser versus deep sclerectomy/viscoanulostomy? What are the risks and benefits of single site versus two site operations? What are the risks and benefits of nuclear expression or phacoemulsification?
link to summary of report on AHRQ site link to evidence report on AHRQ site
|
